Blackmores (ASX:BKL) complete the divestment of Global Therapeautics
[videojs_hls url=’//du7x25at22z7c.cloudfront.net/297417/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/2020/Headlines01_360_201202.jpg’]
Blackmores (ASX:BKL) have completed the divestment of Global Therapeautics to McPherson’s.
A Business Sale Agreement was announced on the 27th October.
Blackmores Chief Executive Officer Alastair Symington said, “We expect Global Therapeutics will flourish as a key business within McPherson’s Health Division.
Shares in Blackmores (ASX:BKL) closed 1.01 per cent lower at $79.19 yesterday.
Copyright 2020 – Finance News Network
Source: Finance News Network